Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BDP Nasal Aerosol HPA-Axis Study in Pediatric PAR
NCT01697956Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in perennial allergic rhinitis (PAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2012; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01697956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697956.